Prescription and use of ward‐delivered nasal high‐flow oxygen and non‐invasive ventilation for people with acute respiratory failure.
Nasal high‐flow therapy with oxygen entrained (HFNO) and non‐invasive ventilation (NIV) are important therapies for managing acute respiratory failure (ARF) in the ward‐based setting. The European Respiratory Society released guidelines in 2022 recommending the use of HFNO over conventional oxygen t...
| Publicado en: | Internal Medicine Journal Vol. 56; no. 5; pp. 908 - 914 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
May2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194753958&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194753958 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14440903 HYC jtl: Internal Medicine Journal issn: 14440903 maglogo: Y pubinfo: dt: May2026 vid: 56 iid: 5 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 194753958 192762155 194753958 194753958 10.1111/imj.70418 194753958 ppf: 908 ppct: 6 formats: tig: atl: Prescription and use of ward‐delivered nasal high‐flow oxygen and non‐invasive ventilation for people with acute respiratory failure. aug: au: Cushnahan, Aiden Harrison, Amelia Buchan, Catherine Naughton, Matthew T. Dabscheck, Eli Smallwood, Natasha affil: Department of Respiratory Medicine, The Alfred, Melbourne Victoria,, Australia sug: subj: Respiratory Failure Therapy Acute Disease Therapy Oxygen Therapy Prescribing Patterns Prescriptions, Non-Drug Respiration, Artificial Noninvasive Procedures Academic Medical Centers Australia Implementation Science Australia Human Male Female Middle Age Aged Aged, 80 and Over Retrospective Design Record Review Audit Chi Square Test Mann-Whitney U Test Nonparametric Statistics Data Analysis Software Descriptive Statistics Positive End-Expiratory Pressure Respiratory Dead Space Mucociliary Clearance Respiratory Airflow Intubation Dyspnea Prevention and Control Continuous Positive Airway Pressure Length of Stay Intensive Care Units Middle Aged: 45-64 years Aged: 65+ years Aged, 80 & over Male Female ab: Nasal high‐flow therapy with oxygen entrained (HFNO) and non‐invasive ventilation (NIV) are important therapies for managing acute respiratory failure (ARF) in the ward‐based setting. The European Respiratory Society released guidelines in 2022 recommending the use of HFNO over conventional oxygen therapy and NIV in patients with hypoxic ARF. We conducted a 12‐month retrospective audit of ward‐based HFNO and NIV use at our hospital to determine prescribing practices for these therapies and to assist with the safe implementation of the recent European Respiratory Society guidelines. We found significant variation in prescribing practices for both HFNO and NIV. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|